Dr Anders on the Investigation of CCR4 Antagonists in Advanced Cancers
Robert Albert Anders, MD, PhD, discusses the rationale for developing CCR4 antagonists for use in patients with advanced cancers, including lymphoma and non–small cell lung cancer.
Source: onclive.com